Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Standard BioTools Inc’s stock clocked out at $1.16, down -5.69% from its previous closing price of $1.23. In other words, the price has decreased by -$5.69 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
To gain a deeper understanding of LAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 16, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $3.50.
On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.Jefferies initiated its Buy rating on April 04, 2024, with a $3.25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 28 ’25 when Casdin Partners Master Fund, L bought 4,820,959 shares for $1.06 per share. The transaction valued at 5,134,321 led to the insider holds 58,846,780 shares of the business.
Black Jeffrey G. bought 57,971 shares of LAB for $123,098 on Nov 12 ’24. On Sep 09 ’24, another insider, Taich Adam, who serves as the Former Officer of the company, bought 45,851 shares for $2.00 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.52 while its Price-to-Book (P/B) ratio in mrq is 0.93.
Stock Price History:
Over the past 52 weeks, LAB has reached a high of $2.74, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is -1.01%, while the 200-Day Moving Average is calculated to be -31.46%.
Shares Statistics:
A total of 377.53M shares are outstanding, with a floating share count of 364.90M. Insiders hold about 3.72% of the company’s shares, while institutions hold 75.48% stake in the company.
